Friday 20 September 2013

Nature Reviews Cardiology - Table of Contents alert Volume 10 Issue 10

Nature Reviews CardiologyWorld Heart Federation

Advertisement
Challenge yourself with Circulation's ECG Challenges!
The Challenge from September 10, 2013 is freely accessible, and anyone can enter a diagnosis.

Visit OpenHeart for archived Challenges - a freely accessible, online resource for professional development and learning, morning rounds, or quickly identifying content for case-based learning sessions.
 
TABLE OF CONTENTS
 
October 2013 Volume 10 Number 10

Nature Reviews Cardiology cover
Impact Factor 10.400 *
In this issue
Research Highlights
News and Views
Correspondence
Reviews

Also this month
 Featured article:
Update on atrial fibrillation catheter ablation technologies and techniques
Jane Dewire & Hugh Calkins




Subscribe
 
Facebook
 
RSS
 
Recommend to library
 
Twitter
 
Advertisement
SciBX: Science-Business eXchange
Collection on Antibiotic Resistance

This special Collection from SciBX: Science-Business eXchange provides an overview of the state of affairs on antibiotic resistance from the scientific, business and regulatory perspectives. 

Click here to access the Collection for free!

Produced with support from:
Cempra Inc., Cubist Pharmaceuticals Inc., Durata Therapeutics Inc., Polyphor Ltd.
 
RESEARCH HIGHLIGHTS

Top

Hypertension: Riociguat therapy for pulmonary hypertension
Published online: 13 August 2013
p549 | doi:10.1038/nrcardio.2013.122

PDF


Arrhythmias: AF pacing in sick sinus syndrome
Published online: 06 August 2013
p550 | doi:10.1038/nrcardio.2013.119

PDF


Genetics: Potassium channelopathy implicated in the pathogenesis of familial PAH
Published online: 13 August 2013
p550 | doi:10.1038/nrcardio.2013.123

PDF


Heart failure: Air pollution linked with heart-failure-related hospitalization and mortality
Published online: 30 July 2013
p551 | doi:10.1038/nrcardio.2013.112

PDF


Risk factors: Kidney stones associated with increased CHD risk in women
Published online: 13 August 2013
p551 | doi:10.1038/nrcardio.2013.124

PDF


Interventional cardiology: Platelet reactivity after stenting
Published online: 13 August 2013
p551 | doi:10.1038/nrcardio.2013.125

PDF


Vascular disease: Peripheral artery disease pandemic
Published online: 20 August 2013
p552 | doi:10.1038/nrcardio.2013.128

PDF


Anticoagulation therapy: Enoxaparin dosing for VTE during pregnancy
Published online: 27 August 2013
p552 | doi:10.1038/nrcardio.2013.131

PDF


Dyslipidaemia: Role of remnant cholesterol in IHD
Published online: 27 August 2013
p553 | doi:10.1038/nrcardio.2013.132

PDF


Atherosclerosis: Addition of niacin to optimal statin therapy does not affect plaque regression
Published online: 06 August 2013
p554 | doi:10.1038/nrcardio.2013.120

PDF


Public health: Echocardiography—no role in population screening
Published online: 13 August 2013
p554 | doi:10.1038/nrcardio.2013.126

PDF


Cardiology
JOBS of the week
Research Associate
University of Louisville - Institute of Molecular Cardiology
POSTDOC in Cardiopulmonary Molecular Biology
Hannover Medical School (MHH)
More Science jobs from
Cardiology
EVENT
World Congress of Cardiology Scientific Sessions 2014
04.05.14
Melbourne, Australia
More science events from
 
NEWS AND VIEWS

Top
Coronary artery disease: Variation in ischaemic heart disease between EU countries
Fausto J. Pinto
Published online: 06 August 2013
p555 | doi:10.1038/nrcardio.2013.116
Ischaemic heart disease (IHD) causes a large number of deaths in the European Union, but a new study reveals important inequalities in IHD mortality between countries. Surveillance systems might help to identify these differences and define tailored treatment strategies, so that the burden of IHD can be reduced across Europe.
Full Text | PDF


Valve disease: Is early surgery beneficial in prosthetic valve endocarditis?
Bernard Prendergast & James Harrison
Published online: 03 September 2013
p556 | doi:10.1038/nrcardio.2013.130
Prosthetic valve endocarditis (PVE) is a devastating disease, and guidelines currently recommend early surgery in patients with PVE and associated complications. However, a study from the International Collaboration on Endocarditis suggests that, after correcting for treatment selection bias and survivor bias, early surgery might not be beneficial.
Full Text | PDF


Congenital heart conditions: Patent foramen ovale closure—not all devices are equal
Bernhard Meier
Published online: 03 September 2013
p558 | doi:10.1038/nrcardio.2013.136
Debate surrounds the best method of treating patent foramen ovale (PFO). Randomized trials suggest that catheter-based closure of PFO is beneficial for secondary stroke prevention; however, with multiple devices available, which performs best in a head-to-head trial? A paper published in the European Heart Journal might have the answer.
Full Text | PDF


 
CORRESPONDENCE

Top
Targeting RV failure and cardiomyocyte injury in acute pulmonary thromboembolism
Jose E. Tanus-Santos
Published online: 20 August 2013
p559 | doi:10.1038/nrcardio.2013.12-c1

Full Text | PDF

 
REPLY

Top
Matrix metalloproteinases in right ventricular failure
Marc A. Simon
Published online: 20 August 2013
p559 | doi:10.1038/nrcardio.2013.12-c2

Full Text | PDF


 
REVIEWS

Top
Pharmacotherapies for lipid modification: beyond the statins
Antonio M. Gotto, Jr & Jennifer E. Moon
Published online: 20 August 2013
p560 | doi:10.1038/nrcardio.2013.117
Statins are the first-line therapy for the prevention and treatment of atherosclerotic vascular disease; however, various other lipid-lowering agents can provide additional beneficial effects when to statin therapy or alternatives for patients who are intolerant to statins. In this Review, Antonio Gotto Jr and Jennifer Moon discuss the mechanisms of action, indications, and clinical data for existing pharmacotherapies for lipid modification, as well as trials of investigational agents that are being developed for cardiovascular risk reduction.
Abstract | Full Text | PDF


Genetic testing for inherited cardiac disease
Arthur A. M. Wilde & Elijah R. Behr
Published online: 30 July 2013
p571 | doi:10.1038/nrcardio.2013.108
Cardiomyopathies and cardiac channelopathies can predispose individuals to sudden cardiac death. The genetics that underlie these phenotypes are complex and incompletely understood. In this Review, Wilde and Behr discuss the indications for genetic testing of index patients, and its use in cascade testing of family members, to guide diagnosis, management, and assessment of prognosis.
Abstract | Full Text | PDF


Cardiac contractility modulation therapy in advanced systolic heart failure
Alexander R. Lyon, Michael A. Samara & David S. Feldman
Published online: 13 August 2013
p584 | doi:10.1038/nrcardio.2013.114
Cardiac contractility modulation has positive inotropic effects in the failing heart, without increasing oxygen consumption. Here, Lyon and colleagues review the preclinical data, mode of action, and clinical evidence for the use of this therapy in patients with chronic heart failure. Long-term application of cardiac contractility modulation seems to improve exercise tolerance and quality of life, and have an acceptable safety profile.
Abstract | Full Text | PDF


Update on atrial fibrillation catheter ablation technologies and techniques
Jane Dewire & Hugh Calkins
Published online: 27 August 2013
p599 | doi:10.1038/nrcardio.2013.121
Atrial fibrillation is one of the most common heart arrhythmias. In this Review, Dewire and Calkins discuss the development and role of catheter ablation to electrically isolate the pulmonary veins in patients with paroxysmal, persistent, or longstanding persistent atrial fibrillation. They go on to highlight novel tools that improve the safety, efficacy, and precision of ablation techniques.
Abstract | Full Text | PDF


Advertisement
New Impact Factor

We are pleased to announce that the new impact factor for Nature Reviews Cardiology is 10.400*.

This places the journal first among all monthly review journals in the Cardiac & Cardiovascular Systems category!

*2012 Journal Citation Reports® (Thomson Reuters, 2013)
 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events
*Journal Citation Reports, Thomson, 2012. Nature Reviews Cardiology was previously published as Nature Clinical Practice Cardiovascular Medicine.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department

For print subscription enquiries, please contact our subscription department

For other enquiries, please contact our feedback department

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group

No comments:

Post a Comment